Rising Focus on Exploring Potential of Stem Cells as Therapeutic Tools in Drug Targeting and Regenerative Medicine to Fuel Revenue Growth of Stem…

NEW YORK, Jan. 10, 2022 /PRNewswire/ --Reports and Data has published its latest report titled "Stem Cells Market By Product (Adult Stem Cells, Human Embryonic Stem Cells, IPS Cells, and Very Small Embryonic-Like Stem Cells), By Technology (Cell Acquisition, Cell Production, Cryopreservation, and Expansion & Sub-Culture), By Therapies (Allogeneic Stem Cell Therapy and Autologous Stem Cell Therapy), and By Application (Regenerative Medicine and Drug Discovery & Discovery), and By Region Forecast To 2028." According to the latest report by Reports and Data, the global stem cells market size was USD 10.13 billion in 2020 and is expected to reach USD 19.31 Billion in 2028 and register a revenue CAGR of 8.4% during the forecast period, 2021-2028.

Read more
Regenerative Medicine: Innovation & Innovators leading online scientific event by IASRM in this pandemic – ThePrint

New Delhi (India), January 10 (ANI/PNN): IASRM have organised a one-day scientific online event on Regenerative Medicine: Innovation & Innovators dated 8th January 2022, in which world-leading doctors and scientist shared their work journey and experience. Some of the leading speakers Dr Manjula Anagani (Padmashree Awardee Gynaecologist), Dr Sharda Jain, Dr Red M Alinsod, Dr Carolyn De Lucia, Dr Alex Bader, Dr Rashad Haddad, Dr Rahul Bhargav, Dr Leila Soudah, Dr Ihsan Naimat, Dr Amr Seifeldin

Read more
JPM22: Pfizer’s big bet on mRNA, Biogen ‘proven wrong’ on Aduhelm price and the next cell therapies – BioPharma Dive

Biotechnology stocks ended the first day of the J.P. Morgan Healthcare Conference in the green, but only barely.By Monday afternoon, a closely followed index of the industry was up a fraction of a percent, marking a tepid start for a conference that's historically been able to drum up excitement in drug companies. After a difficult end to 2021 for many biotechs, hopes were also high that dealmaking or major announcements might spark a rally

Read more
Severe Combined Immunodeficiency Treatment Market: Availability of Drugs and Immune-related Treatments Are Anticipated to Drive the Global Market -…

Severe Combined Immunodeficiency Treatment (SCID) Market: Introduction Severe combined immunodeficiency (SCID) is a group of rare disorders caused by mutation in different genes. These genes are responsible for the development and functioning of the immune system. These disorders are life-threatening or fatal usually in the first two years of a childs life.

Read more
Overview – Brain Tumor Stem Cell Research Lab – Mayo …

Dr. Quinones-Hinojosa's Brain Tumor Stem Cell Research Lab at Mayo Clinic studies the molecular pathways of glioblastoma, chordoma and metastatic brain cancer to find new therapies for patients. The Brain Tumor Stem Cell Research Laboratory of Alfredo Quinones-Hinojosa, M.D., focuses on elucidating molecular and cellular pathways involved in the progression of tumors arising in the central nervous system, in particular glioblastoma

Read more
EBMT trial demonstrates improvements in immunosuppressive treatment of patients with Severe Aplastic Anemia – EurekAlert

Over the past three decades, efforts to improve the results of standard treatment for patients with Severe Aplastic Anemia have been largely unsuccessful. The phase III RACE trial, sponsored by the EBMT, published on January 6, 2022, by the New England Journal of Medicinenow demonstrates that adding Eltrombopag to standard immunosuppressive treatment is safe and increases response rates in patients with this rare, yet potentially fatal disease. Severe Aplastic Anemia (SAA) is a rare hematological disease in which the bone marrow does not produce enough new blood cells.

Read more
CMML vs. CML: What’s the Difference? – Healthline

Chronic myelomonocytic leukemia (CMML) and chronic myeloid leukemia (CML) are two types of cancers that affect the blood and bone marrow. In both types, certain blood cells multiply out of control. This can crowd out healthy blood cells and lead to worsening symptoms as the cancer spreads throughout the body.

Read more